Literature DB >> 23859244

Intracranial hypertension due to meningioma of the unique transverse sinus.

G Mariniello1, A Giamundo, R Donzelli, R Severino, C Russo, A Elefante, F Maiuri.   

Abstract

We describe a 28-year-old woman with intracranial hypertension due to a meningioma invading the unique transverse sinus (with absent contralateral sinus). Clinical remission and normalization of orbital echography were obtained by resection of the intradural tumor and peeling of the dural attachment. In such cases, resection and reconstruction of the involved sinus segment is at high risk of venous infarction. Endovascular stenting of the obstructed sinus is a valid alternative when the stenosis is not remarkable. Single tumor removal may lead to partial sinus decompression and increased venous flow, resulting in long-term clinical remission.

Entities:  

Mesh:

Year:  2013        PMID: 23859244      PMCID: PMC5228730          DOI: 10.1177/197140091302600211

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  16 in total

1.  Riedel's thyroiditis and cerebral venous sinuses thrombosis: a case report.

Authors:  O Piazza; E De Robertis; F Caranci; M Quarantelli; R Tufano
Journal:  Panminerva Med       Date:  2010-12       Impact factor: 5.197

2.  Syndrome simulating pseudotumor cerebri caused by partial transverse venous sinus obstruction in metastatic prostate cancer.

Authors:  A W Kim; J D Trobe
Journal:  Am J Ophthalmol       Date:  2000-02       Impact factor: 5.258

3.  Results of attempted radical tumor removal and venous repair in 100 consecutive meningiomas involving the major dural sinuses.

Authors:  Marc P Sindou; Jorge E Alvernia
Journal:  J Neurosurg       Date:  2006-10       Impact factor: 5.115

4.  Spontaneous peritumoral haemorrhage associated with sinus confluence meningioma: case report.

Authors:  K K Barua; N Tamaki; K Ehara; T Nagashima; H Suzuki
Journal:  Surg Neurol       Date:  2000-09

Review 5.  Neurosurgery and the intracranial venous system.

Authors:  M Sindou; J Auque; E Jouanneau
Journal:  Acta Neurochir Suppl       Date:  2005

6.  Endovascular treatment of idiopathic intracranial hypertension: clinical and radiologic outcome of 10 consecutive patients.

Authors:  A Donnet; P Metellus; O Levrier; C Mekkaoui; S Fuentes; H Dufour; J Conrath; F Grisoli
Journal:  Neurology       Date:  2008-02-19       Impact factor: 9.910

7.  Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis.

Authors:  R I Farb; I Vanek; J N Scott; D J Mikulis; R A Willinsky; G Tomlinson; K G terBrugge
Journal:  Neurology       Date:  2003-05-13       Impact factor: 9.910

8.  Radiosurgery as definitive management of intracranial meningiomas.

Authors:  Douglas Kondziolka; David Mathieu; L Dade Lunsford; Juan J Martin; Ricky Madhok; Ajay Niranjan; John C Flickinger
Journal:  Neurosurgery       Date:  2008-01       Impact factor: 4.654

Review 9.  Cranial venous outflow obstruction and pseudotumor Cerebri syndrome.

Authors:  B K Owler; G Parker; G M Halmagyi; I H Johnston; M Besser; J D Pickard; J N Higgins
Journal:  Adv Tech Stand Neurosurg       Date:  2005

Review 10.  Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting.

Authors:  J N P Higgins; C Cousins; B K Owler; N Sarkies; J D Pickard
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

View more
  2 in total

1.  Evaluating diploic vein blood flow using time-resolved whole-head computed tomography angiography and determining the positional relationship between typical craniotomy approaches and diploic veins in patients with meningioma.

Authors:  Kei Yamashiro; Akira Wakako; Tatsuo Omi; Kazuhiro Murayama; Daijiro Kojima; Jun Muto; Kazuhide Adachi; Mitsuhiro Hasegawa; Yuichi Hirose
Journal:  Acta Neurochir (Wien)       Date:  2022-08-25       Impact factor: 2.816

2.  Venous hypertension caused by a meningioma involving the sigmoid sinus: case report.

Authors:  Koichiro Sumi; Naoki Otani; Fumi Mori; Shun Yamamuro; Hideki Oshima; Atsuo Yoshino
Journal:  BMC Neurol       Date:  2021-03-17       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.